Quarterly report pursuant to Section 13 or 15(d)

Loans Receivable - Components (Details)

v3.24.2.u1
Loans Receivable - Components (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 01, 2023
Jun. 30, 2024
Mar. 31, 2023
Jun. 30, 2024
Dec. 31, 2023
Aug. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   $ 8,904   $ 8,904 $ 8,968  
Less allowance for expected credit losses   (7,902)   (7,902) (7,902)  
Loans receivable   1,002   1,002 1,066  
Additional allowance for credit losses   0   0    
Teneo Fund SPVi LLC note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   5,558   5,558 5,622  
Pharma EU, LLC note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   1,410   1,410 1,410  
A&R note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   710   710 710  
SSZ and Elev8 note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   1,002   1,002 1,002  
Pure Hana Synergy note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable   $ 224   $ 224 $ 224  
Little Beach Harvest Note            
Accounts, Notes, Loans and Financing Receivable [Line Items]            
Total loans receivable $ 0          
Interest rate on loans receivable           9.00%
Interest and Fee Income, Loans and Leases     $ 64      
Write off of loan receivable including both principal and accrued interest $ 5,135